<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-21897" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Forced Expiratory Volume</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>David</surname>
            <given-names>Sharoon</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldin</surname>
            <given-names>Jennifer</given-names>
          </name>
          <aff>Wright State University School of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Edwards</surname>
            <given-names>Christopher W.</given-names>
          </name>
          <aff>University of Arkansas</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sharoon David declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jennifer Goldin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christopher Edwards declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-21897.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Forced expiratory volume (FEV) is a critical measurement in pulmonary function testing that quantifies the volume of air a person can forcibly exhale from the lungs within a specific time frame following maximal inhalation.&#x000a0;FEV is denoted with a subscript indicating the measurement duration in seconds (eg, 1 and 6 seconds), with FEV<sub>1&#x000a0;</sub>and FEV<sub>6</sub>&#x000a0;being the most common parameters.<xref ref-type="bibr" rid="article-21897.r1">[1]</xref><xref ref-type="bibr" rid="article-21897.r2">[2]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/28030">Pulmonary Function Tests</ext-link>," for more information.&#x000a0;This test is essential for diagnosing and monitoring respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other obstructive and restrictive lung diseases (see&#x000a0;<bold>Image.</bold>&#x000a0;Forced Expiratory Volume).</p>
        <p>The most commonly used parameter, FEV<sub>1</sub>, is the primary spirometric variable for assessing the severity of airflow obstruction and evaluating a patient's response to treatment. By reporting FEV<sub>1</sub>&#x000a0;as a Z-score instead of a percent predicted, healthcare professionals can eliminate biases related to age, sex, and height, enabling a more accurate assessment of lung function impairment and the development of tailored management strategies.</p>
        <p>The American Thoracic Society's current guidelines recommend replacing race- and ethnicity-specific equations with "race-neutral" averaged reference equations, such as the Global Lung Function Initiative (GLI) reference equations, while recognizing the need for further research to assess the impact of these changes.<xref ref-type="bibr" rid="article-21897.r3">[3]</xref> FEV<sub>6</sub>&#x000a0;can be a useful alternative to forced vital capacity (FVC).<xref ref-type="bibr" rid="article-21897.r2">[2]</xref><xref ref-type="bibr" rid="article-21897.r4">[4]</xref><xref ref-type="bibr" rid="article-21897.r5">[5]</xref><xref ref-type="bibr" rid="article-21897.r6">[6]</xref>&#x000a0;Understanding and applying FEV measurements are essential for providing effective respiratory care and improving patient outcomes.</p>
      </sec>
      <sec id="article-21897.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Spirometry is a test used to measure the ability of a person to inhale and exhale air over a specific period of&#x000a0;time. Key parameters include FEV<sub>1</sub>&#x000a0;and either FVC or FEV<sub>6</sub>. Factors such as reduced patient effort, inadequate inhalation, difficulty following instructions, and certain medical conditions can impact the accuracy of spirometry results.<xref ref-type="bibr" rid="article-21897.r7">[7]</xref>&#x000a0;Technicians conducting the test must coach and motivate the patient to exert maximum effort to ensure accurate results. In the past, clinicians reported FEV as a percentage of predicted values based on age, gender, height, weight, and ethnicity.<xref ref-type="bibr" rid="article-21897.r8">[8]</xref><xref ref-type="bibr" rid="article-21897.r9">[9]</xref>&#x000a0;A value of 80% of the predicted was traditionally considered the lower limit of normal (LLN).<xref ref-type="bibr" rid="article-21897.r10">[10]</xref>&#x000a0;</p>
        <p>The American Thoracic Society and European Respiratory Society now recommend using the fifth percentile, corresponding to a Z-score of &#x02212;1.645 or lower, as the LLN to eliminate biases related to age, height, and weight bias and to account for the natural age-related decline in the FEV<sub>1</sub>&#x000a0;to FVC ratio (FEV<sub>1</sub>/FVC).<xref ref-type="bibr" rid="article-21897.r11">[11]</xref><xref ref-type="bibr" rid="article-21897.r12">[12]</xref><xref ref-type="bibr" rid="article-21897.r13">[13]</xref>&#x000a0;The Z-score is a combination of the percent predicted value and the between-subject variability, which provides a single number that accounts for age- and height-related lung function variability&#x000a0;related to healthy individuals.</p>
        <p>Growing evidence indicates that race- and ethnicity-specific equations underestimate the severity of pulmonary disease in Black populations. Current guidelines from the American Thoracic Society and European Respiratory Society recommend using race-neutral equations, such as the GLI&#x000a0;reference equations. Although the GLI reference equations include data from individuals of various self-reported racial and ethnic backgrounds, race selection is not necessary for applying the formula.</p>
        <p>Ongoing research is essential to assess the impact of adopting a race-neutral approach. A recent study indicates that race-based and race-neutral equations yield similar predictions for symptoms, healthcare utilization, and mortality. However, the prevalence of nonobstructive ventilatory impairments decreases among self-identified White and Hispanic individuals, from approximately 4.5% to 1.5%, while it increases among self-identified Black individuals, from 5.7% to 14%.<xref ref-type="bibr" rid="article-21897.r14">[14]</xref> This reclassification could significantly affect standards for disqualification from certain jobs, such as firefighting, as well as eligibility for disability, prioritization for lung transplants, and disability compensation for veterans.</p>
        <p>The FEV<sub>1</sub>/FVC&#x000a0;represents the fraction of air a&#x000a0;patient exhales in the first second. This value is the most critical parameter for detecting airflow obstruction. Traditionally, an FEV<sub>1</sub>/FVC of 0.7 has been considered normal. However, this fixed ratio can result in overdiagnosis of airflow obstruction in patients aged 70 or older and underdiagnosis in younger individuals. Reporting FEV<sub>1</sub>/FVC&#x000a0;as a Z-score, with a threshold of &#x02212;1.645 or lower as the LLN, helps reduce the incidence of misdiagnosis.</p>
        <p>Spirometry requires substantial effort and can increase pressure in the chest, abdomen, head, and eyes. Patients who have experienced a myocardial infarction within the prior month or who have unstable angina should avoid spirometry. Additionally, patients who have undergone abdominal, intracranial, or eye surgery, or those with a pneumothorax in the prior 6 weeks, should not undergo spirometry testing.</p>
      </sec>
      <sec id="article-21897.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Patients may undergo spirometry for various reasons, including chronic persistent cough, wheezing, dyspnea, and exertional cough or chest pain. Pulmonary function tests objectively measure a patient's response to bronchodilators, monitor disease progression, assess levels of respiratory impairment, and evaluate the effects of exposure to chemicals in the workplace. Technicians record the highest FVC,&#x000a0;FEV<sub>1</sub>, and&#x000a0;FEV<sub>6</sub>&#x000a0;from 3 attempts as the final result. A low FVC may result from poor patient effort, airflow limitations, or restrictions caused by diseases affecting the lung parenchyma, pleura, or thoracic cage. FEV<sub>1</sub> measures the mechanical properties of the lungs;&#x000a0;FEV<sub>1</sub>/FVC helps differentiate between obstructive and restrictive lung diseases. FEV<sub>1</sub> accounts for approximately 75% to 85% of the FVC in healthy lungs.</p>
        <p>Both restrictive and obstructive disorders cause a reduction in FEV<sub>1</sub>. In obstructive diseases, FEV<sub>1</sub> is disproportionately reduced compared to FVC, resulting in FEV<sub>1</sub>/FVC&#x000a0;falling below the&#x000a0;LLN. While FEV<sub>1&#x000a0;</sub>is the most important&#x000a0;measurement for assessing the severity of airflow obstruction, FEV<sub>1</sub>/FVC&#x000a0;is essential for detecting airflow obstruction. However, this ratio is still not a reliable indicator of disease severity. Clinicians use&#x000a0;FEV<sub>1&#x000a0;</sub>to monitor disease severity in patients with COPD and asthma.</p>
        <p>FEV<sub>1</sub>, FVC, and total lung capacity are reduced in restrictive disorders, leading to a normal or elevated FEV<sub>1</sub>/FVC. Please see StatPearls' companion resources, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/21034">Emphysema</ext-link>" and "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/21035">Chronic Emphysema</ext-link>," for more information.<xref ref-type="bibr" rid="article-21897.r15">[15]</xref>&#x000a0;Some authors suggest that FEV<sub>1</sub>/FEV<sub>6</sub>&#x000a0;may serve as a replacement for FEV<sub>1</sub>/FVC, as FEV<sub>6</sub>&#x000a0;offers improved accuracy, requires less physical effort, and is more reproducible.<xref ref-type="bibr" rid="article-21897.r16">[16]</xref></p>
        <p>The most common causes of decreased FEV<sub>1</sub>&#x000a0;include airway obstruction&#x000a0;from bronchospasm, airway inflammation, loss of lung elastic recoil, and increased airway secretions. The change in&#x000a0;FEV<sub>1</sub>&#x000a0;after the administration of inhaled bronchodilators can help assess the reversibility of airway obstruction. An increase in FEV<sub>1</sub>&#x000a0;of 10% or more following bronchodilator use is considered a positive response.<xref ref-type="bibr" rid="article-21897.r17">[17]</xref> A positive response is typically observed in reversible airway obstruction, such as asthma. However, clinicians should be aware that a lack of significant improvement in FEV<sub>1</sub> alone does not necessarily indicate that the patient will not benefit clinically from bronchodilator therapy.<xref ref-type="bibr" rid="article-21897.r18">[18]</xref>&#x000a0;</p>
        <p>Additional indicators of beneficial bronchodilator effects include significant increases in inspiratory capacity (IC) or vital capacity (VC) after treatment. In contrast,&#x000a0;nonreversible obstruction, as seen in patients with COPD, will not show a significant positive response to bronchodilator administration.&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/21034">Emphysema</ext-link>," for more information.<xref ref-type="bibr" rid="article-21897.r15">[15]</xref><xref ref-type="bibr" rid="article-21897.r19">[19]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-21897.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>FEV is a crucial measurement in pulmonary function testing that quantifies the volume of air a person can forcibly exhale within a specific timeframe following maximal inhalation. This measurement is crucial for diagnosing and monitoring respiratory conditions such as asthma, COPD, and other obstructive or restrictive lung diseases.</p>
        <p>FEV<sub>1</sub>, combined with FVC, is the most commonly used parameter for identifying airway obstruction. FEV<sub>1</sub> is also a reliable indicator of disease severity and is used to monitor patients with COPD and asthma. However, comparing FEV<sub>1</sub> to predicted values based on age, gender, height, and ethnicity is no longer recommended.</p>
        <p>All spirometry values currently use the fifth percentile as the LLN, corresponding to a Z-score of &#x02212;1.645 or lower, to eliminate age, sex, and height bias and support tailored management strategies.<xref ref-type="bibr" rid="article-21897.r20">[20]</xref>&#x000a0;in addition, race-neutral formulas are recommended for calculating predicted spirometry values to reduce racial bias in healthcare.&#x000a0;</p>
        <p>Accurate spirometry depends on good patient effort, proper inhalation, and the ability to follow instructions, as decreased effort can result in misdiagnosis and inappropriate treatment. In obstructive diseases, FEV<sub>1</sub> is&#x000a0;disproportionately reduced compared to FVC, leading to a low FEV<sub>1</sub>/FVC&#x000a0;with a Z-score of &#x02212;1.645 or lower. In restrictive disorders, both FEV<sub>1</sub> and FVC are reduced, causing FEV<sub>1</sub>/FVC&#x000a0;to remain normal or elevated. Some experts suggest using the FEV<sub>1</sub>/FEV<sub>6</sub>&#x000a0;instead of FEV<sub>1</sub>/FVC, as FEV<sub>6</sub> offers greater accuracy, lower physical demands, and improved reproducibility.</p>
        <p>The&#x000a0;FEV<sub>1</sub> response&#x000a0;to inhaled bronchodilators can help assess the reversibility of airway obstruction. However, clinicians should be aware that a lack of significant improvement in FEV<sub>1</sub> does not necessarily indicate that the patient will not benefit from bronchodilator therapy. Clinicians should consider changes in other values, such as IC and VC. Understanding and utilizing FEV measurements are fundamental in delivering effective respiratory care and improving patient outcomes.</p>
        <p>Enhancing patient-centered care, outcomes, safety, and team performance related to FEV measurement requires a multidisciplinary approach involving physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals. Physicians and advanced practitioners must be proficient in conducting and interpreting spirometry tests, especially FEV<sub>1</sub> and FVC, to effectively diagnose and monitor respiratory conditions such as asthma and COPD.</p>
        <p>Healthcare team members must collaborate to prepare patients for spirometry, ensure accurate technique, and educate them on the importance of these tests and proper inhaler use. Adhering to standardized spirometry protocols and participating in quality improvement initiatives are essential for enhancing accuracy and effectiveness.</p>
        <p>Effective interprofessional communication is crucial and can be improved through meticulous documentation and timely sharing of specialist input and test results. Collaborative care planning and patient education are essential strategies, enabling all healthcare team members to work together in creating and adjusting treatment plans based on spirometry results and patient responses. By integrating these skills, strategies, and communication practices, healthcare teams can significantly enhance patient-centered care, safety, and outcomes in managing respiratory conditions through FEV measurements.</p>
      </sec>
      <sec id="article-21897.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=21897&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=21897">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/21897/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=21897">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-21897.s6">
        <fig id="article-21897.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Forced Expiratory Volume. Forced expiratory volume measures the volume of air an individual can exhale from the lungs during a forced breath over a specified duration in seconds (<italic toggle="yes">t</italic>). Contributed by&#x000a0;S Bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Forced__Expiratory__Volume__3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-21897.s7">
        <title>References</title>
        <ref id="article-21897.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Matarese</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sardu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santulli</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Why is chronic obstructive pulmonary disease linked to atrial fibrillation? A systematic overview of the underlying mechanisms.</article-title>
            <source>Int J Cardiol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>276</volume>
            <fpage>149</fpage>
            <page-range>149-151</page-range>
            <pub-id pub-id-type="pmid">30446289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>TY</given-names>
              </name>
            </person-group>
            <article-title>[Value of forced expiratory volume in 6 seconds (FEV(6)) in the evaluation of pulmonary function in Chinese elderly males].</article-title>
            <source>Zhonghua Yi Xue Za Zhi</source>
            <year>2017</year>
            <month>May</month>
            <day>30</day>
            <volume>97</volume>
            <issue>20</issue>
            <fpage>1556</fpage>
            <page-range>1556-1561</page-range>
            <pub-id pub-id-type="pmid">28592061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhakta</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Bime</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kaminsky</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>McCormack</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Thakur</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Stanojevic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baugh</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lovinsky-Desir</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adamson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Witonsky</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wise</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Forno</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Balmes</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mageto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Masekela</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Irvin</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schwartzstein</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neptune</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wisnivesky</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>VE</given-names>
              </name>
              <name>
                <surname>Burney</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2023</year>
            <month>Apr</month>
            <day>15</day>
            <volume>207</volume>
            <issue>8</issue>
            <fpage>978</fpage>
            <page-range>978-995</page-range>
            <pub-id pub-id-type="pmid">36973004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Castillo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>The accuracy of a handheld "disposable pneumotachograph device" in the spirometric diagnosis of airway obstruction in a Chinese population.</article-title>
            <source>Int J Chron Obstruct Pulmon Dis</source>
            <year>2018</year>
            <volume>13</volume>
            <fpage>2351</fpage>
            <page-range>2351-2360</page-range>
            <pub-id pub-id-type="pmid">30122915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reyes-Garc&#x000ed;a</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Torre-Bouscoulet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Padilla</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>CONTROVERSIES AND LIMITATIONS IN THE DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE.</article-title>
            <source>Rev Invest Clin</source>
            <year>2019</year>
            <volume>71</volume>
            <issue>1</issue>
            <fpage>28</fpage>
            <page-range>28-35</page-range>
            <pub-id pub-id-type="pmid">30810541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alotaibi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Borg</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zwar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Holland</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Bonevski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mahal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>George</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Different Case Finding Approaches to Optimise COPD Diagnosis: Evidence from the RADICALS Trial.</article-title>
            <source>Int J Chron Obstruct Pulmon Dis</source>
            <year>2023</year>
            <volume>18</volume>
            <fpage>1543</fpage>
            <page-range>1543-1554</page-range>
            <pub-id pub-id-type="pmid">37492489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derom</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Weel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Liistro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Buffels</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schermer</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lammers</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wouters</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Decramer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Primary care spirometry.</article-title>
            <source>Eur Respir J</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>197</fpage>
            <page-range>197-203</page-range>
            <pub-id pub-id-type="pmid">18166597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zakaria</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harif</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Al-Rahbi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>CBA</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Gender Differences and Obesity Influence on Pulmonary Function Parameters.</article-title>
            <source>Oman Med J</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>34</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-48</page-range>
            <pub-id pub-id-type="pmid">30671183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Reference values for lung function screening in 10- to 81-year-old, healthy, never-smoking residents of Southeast China.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>34</issue>
            <fpage>e11904</fpage>
            <pub-id pub-id-type="pmid">30142794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shapira</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Krubiner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ehrenwald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shapira</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zeltser</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berliner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rogowski</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Shenhar-Tsarfaty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bar-Shai</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Eosinophil levels predict lung function deterioration in apparently healthy individuals.</article-title>
            <source>Int J Chron Obstruct Pulmon Dis</source>
            <year>2019</year>
            <volume>14</volume>
            <fpage>597</fpage>
            <page-range>597-603</page-range>
            <pub-id pub-id-type="pmid">30880949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Banjade</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ghamande</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Surani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines Reviewed.</article-title>
            <source>Open Respir Med J</source>
            <year>2024</year>
            <volume>18</volume>
            <fpage>e18743064279064</fpage>
            <pub-id pub-id-type="pmid">38660684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhakta</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>McGowan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Borg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kivastik</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Sylvester</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Burgos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-R&#x000ed;o</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Skloot</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McCormack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mottram</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Irvin</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Steenbruggen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Coates</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Kaminsky</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>European Respiratory Society/American Thoracic Society technical statement: standardisation of the measurement of lung volumes, 2023 update.</article-title>
            <source>Eur Respir J</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>62</volume>
            <issue>4</issue>
            <pub-id pub-id-type="pmid">37500112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Sa'idi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Berton</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Neder</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>The 2022 ERS/ATS z-score classification to grade airflow obstruction: relationship with exercise outcomes across the spectrum of COPD severity.</article-title>
            <source>Eur Respir J</source>
            <year>2024</year>
            <month>Aug</month>
            <volume>64</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">38936965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diao</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Khazanchi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nguemeni Tiako</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Witonsky</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Pierson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rajpurkar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Elhawary</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Melas-Kyriazi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Farhat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borrell</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Burchard</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Manrai</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Implications of Race Adjustment in Lung-Function Equations.</article-title>
            <source>N Engl J Med</source>
            <year>2024</year>
            <month>Jun</month>
            <day>13</day>
            <volume>390</volume>
            <issue>22</issue>
            <fpage>2083</fpage>
            <page-range>2083-2097</page-range>
            <pub-id pub-id-type="pmid">38767252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gallucci</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carbonara</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pacilli</surname>
                <given-names>AMG</given-names>
              </name>
              <name>
                <surname>di Palmo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ricci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nava</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Use of Symptoms Scores, Spirometry, and Other Pulmonary Function Testing for Asthma Monitoring.</article-title>
            <source>Front Pediatr</source>
            <year>2019</year>
            <volume>7</volume>
            <fpage>54</fpage>
            <pub-id pub-id-type="pmid">30891435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatt</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YI</given-names>
              </name>
              <name>
                <surname>Wells</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Ramsdell</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Foreman</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Stinson</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Make</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dransfield</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>335</fpage>
            <page-range>335-41</page-range>
            <pub-id pub-id-type="pmid">24450777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stanojevic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaminsky</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Aliverti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Barjaktarevic</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cooper</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Culver</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Derom</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Hallstrand</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Leuppi</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>MacIntyre</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McCormack</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosenfeld</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Swenson</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>ERS/ATS technical standard on interpretive strategies for routine lung function tests.</article-title>
            <source>Eur Respir J</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>60</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">34949706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beasley</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Agusti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calverley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chipps</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Del Olmo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Papi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Price</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Reddel</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>M&#x000fc;llerov&#x000e1;</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rapsomaniki</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2024</year>
            <month>Feb</month>
            <day>15</day>
            <volume>209</volume>
            <issue>4</issue>
            <fpage>390</fpage>
            <page-range>390-401</page-range>
            <pub-id pub-id-type="pmid">38029294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fortis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comellas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Make</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Hersh</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Bodduluri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Georgopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Criner</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Dransfield</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Bhatt</surname>
                <given-names>SP</given-names>
              </name>
              <collab>COPDGene Investigators&#x02013;Core Units: &#x0003c;italic&#x0003e;Administrative Center&#x0003c;/italic&#x0003e;, COPDGene Investigators&#x02013;Clinical Centers: &#x0003c;italic&#x0003e;Ann Arbor VA&#x0003c;/italic&#x0003e;</collab>
            </person-group>
            <article-title>Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.</article-title>
            <source>Ann Am Thorac Soc</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>16</volume>
            <issue>7</issue>
            <fpage>826</fpage>
            <page-range>826-835</page-range>
            <pub-id pub-id-type="pmid">30908927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-21897.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schiavi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ryu</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Martini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Balasubramanian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McCormack</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Fortis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Bonini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hersh</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Application of the ERS/ATS Spirometry Standards and Race-Neutral Equations in the COPDGene Study.</article-title>
            <source>Am J Respir Crit Care Med</source>
            <year>2024</year>
            <month>Apr</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">38607551</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
